Dediabetes Logo
Questions
Published answers connected to evidence
Clinical Reference
Detailed intervention and outcome dossiers
Latest Research
Newest studies
About
How deDiabetes works
Settings
Login / Sign-up
Research Summary
Analyzed using Evidence Intelligence™

Telemedicine improves glucose control in diabetes patients.

Powered by the Dediabetes Evidence Intelligence™ framework

Last updated August 29, 2026

Key finding

HbA1c decreased by 0.38% in Group A (p < 0.05)

This study evaluated the impact of a web-based telemedicine system on glucose control in insulin-treated diabetes patients, finding significant improvements in HbA1c levels.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated the impact of a web-based telemedicine system on glucose control in insulin-treated diabetes patients, finding significant improvements in HbA1c levels.

Clinical relevance

Improving glucose control in diabetes is crucial for reducing long-term complications. This study suggests that telemedicine can enhance patient engagement and self-management, leading to better health outcomes. As diabetes prevalence rises, effective management strategies like telemedicine could play a vital role in improving patient care.

Keep in mind

Limited sample size may affect generalizability Short follow-up period may not capture long-term effects Potential selection bias in participant recruitment

Published in

Journal Reference

Publication details and source links for this paper.

S. DM, P. P, S. C, et al. The use of a web-based telemedicine system improves glucose control in insulin-treated diabetes. Journal of Endocrinological Investigation. 2022;45(9):1663-1671. doi:10.1007/s40618-022-01802-w

View DOIView on PubMedView on PMC

Main Effects

HbA1c decreased by 0.38% in the telemedicine group (p < 0.05)

28.6% of telemedicine patients achieved HbA1c < 7% compared to 11.1% in the standard group (p = 0.02)

14.3% of telemedicine patients had HbA1c > 8.5% compared to 35.2% in the standard group after 3 months (p < 0.05)

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Self-monitoring of blood glucose and HbA1c, Percentage of patients with HbA1c < 7%, Percentage of patients with HbA1c > 8.5% after 3 months.

This study contributes evidence to

Intervention

Self-monitoring of blood glucose

Outcome

HbA1c

Evidence topic

HbA1c Reduction

Primary intervention

Self-monitoring of blood glucose

Primary outcomes

  • HbA1c
  • Percentage of patients with HbA1c < 7%
  • Percentage of patients with HbA1c > 8.5% after 3 months

Evidence topics

HbA1c Reduction

Primary intervention

Self-monitoring of blood glucose

Primary outcomes

HbA1cPercentage of patients with HbA1c < 7%Percentage of patients with HbA1c > 8.5% after 3 months

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

3
Evidence pairs
3
Relationships
1
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 59

1

Related topics

3

Evidence pairs

603

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 3 evidence relationships
  • Includes primary outcome data
  • Linked to 1 direct semantic evidence topic

Topic contributions

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

HbA1c Reduction

matched_outcome

Core evidence

Study findings

The primary outcomes reported in this study.

HbA1c

Self-monitoring of blood glucose → HbA1c

Self-monitoring of blood glucose → HbA1c

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 4 studies
ImpactScore™
69
Positive
ConsistencyScore™
35
mixed
Supporting studies: Based on 4 studies
Add to Evidence Tracker

Percentage of patients with HbA1c < 7%

Self-monitoring of blood glucose → Percentage of patients with HbA1c < 7%

Self-monitoring of blood glucose → Percentage of patients with HbA1c < 7%

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Percentage of patients with HbA1c > 8.5% after 3 months

Self-monitoring of blood glucose → Percentage of patients with HbA1c > 8.5% after 3 months

Self-monitoring of blood glucose → Percentage of patients with HbA1c > 8.5% after 3 months

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Telemedicine group saw a 0.38% decrease in HbA1c (p < 0.05)
  • 28.6% of telemedicine patients achieved HbA1c < 7% (p = 0.02)
  • 14.3% of telemedicine patients had HbA1c > 8.5% after 3 months (p < 0.05)
who this applies

Who this applies to

  • Adults with insulin-treated diabetes
  • Patients seeking improved glucose management strategies
keep in mind

Keep in Mind

  • Results may not apply to non-insulin-treated diabetes patients
  • Findings are based on a specific telemedicine intervention
  • Further research needed to confirm long-term benefits
between the lines

Between the Lines

  • Limited sample size may affect generalizability
  • Short follow-up period may not capture long-term effects
  • Potential selection bias in participant recruitment

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Powered by the Dediabetes Evidence Intelligence™ framework

This study contributes to evidence on Self-monitoring of blood glucose and HbA1c, Self-monitoring of blood glucose and Percentage of patients with HbA1c < 7%.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Self-monitoring of blood glucose lower HbA1c?

Strong Evidence

Self-monitoring of blood glucose may lower HbA1c.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Self-monitoring of blood glucose improve percentage of patients with HbA1c < 7%?

Emerging Evidence

Self-monitoring of blood glucose appears to improve percentage of patients with HbA1c < 7%.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage of patients with HbA1c < 7%

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence

Does Self-monitoring of blood glucose improve percentage of patients with HbA1c > 8.5% after 3 months?

Emerging Evidence

Self-monitoring of blood glucose appears to improve percentage of patients with HbA1c > 8.5% after 3 months.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage of patients with HbA1c > 8.5% after 3 months

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
View Full Evidence
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Evidence topics

Follow the topics this study contributes to.

HbA1c Reduction Evidence Hub

Explore in Evidence Explorer

Open broader Evidence Explorer views for this relationship.

All studies on Self-monitoring of blood glucose and HbA1cAll studies on Self-monitoring of blood glucose and Percentage of patients with HbA1c < 7%All studies on Self-monitoring of blood glucose and Percentage of patients with HbA1c > 8.5% after 3 months

Related research

Read related research summaries.

isCGM does not improve sleep quality in young adults with T1DAdding diabetes medications to metformin improves glycemic control in adults with T2 diabetes.HRS-7535 improves glycemic control in adults with type 2 diabetesLiraglutide and Empagliflozin Improve Heart Function in DiabetesRT-CGM improves glucose control in adults with T2D

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.